This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Nucleotide Market

Market Insights on Nucleotide covering sales outlook, demand forecast & up-to-date key trends

Nucleotide Market By By Technology (Gene chips & microarrays, SNP by pyrosequencing), Application (Pharmaceuticals, Diagnostics research, Food & beverage additive)& Region - Forecast to 2021 - 2031

Nucleotides Market by Technology

[350 Pages Report] Newly released data from nucleotides market analysis shows that global demand of overall nucleotides market enjoyed year-on-year growth of 5.8% in 2021 to total US$ 559.9 Mn and it is expected to grow with a CAGR of 6.1% over the forecasted period.

In the past few years, the consumer base around the globe is becoming aware of the usage of premixes in infant nutrition applications. Thus consumers started opting for infant nutrition products containing premixes which are expected to trigger growth to the nucleotides market.

In addition to this, the disposable income of the consumer base around the globe is increasing and, as a result, their propensity to spend on food products with improved health benefits is also increasing. Thus the consumer base around the globe started opting for food products with health beneficial ingredients such as nucleotides.

Sales of nucleotides will represent 5.8% of the overall demand in the global customized premix market. The increasing demand for food premixes owing to health benefits associated with it is propelling growth to the overall customized premix market. Moreover, growing awareness among the pet owners regarding the diet of their pet is increasing demand for feed premixes which is expected to propel growth to the nucleotides market.

2016-2020 Nucleotides Market Outlook in Comparison to 2021-2031 Growth Forecast

The global nucleotides market is expected to value at US$ 559.9 Mn in 2021. However, it is projected to reach US$ 1,010.5 Mn by the end of 2031 growing with a CAGR of 6.1%.

The global nucleotide market is now seeing rapid expansion. To a certain extent, growth is due to increased demand from a variety of end consumers. Nucleotides, for example, have seen a significant surge in use in animal feed additives, the food and beverage sector, pharmaceuticals, and research and diagnostics. The market is expected to see a significant increase in demand in the coming years. As customers become more aware of the adverse consequences of savoury additives, sales of nucleotide-based flavour enhancers are expected to rise in the coming years.

Furthermore, the market's growth prospects will be boosted by the expanding spectrum of use in the pharmaceuticals sector, particularly in Canada and the United States, as well as continually rising demand from the cattle industry.

Customize this Report

Let us know your requirement to get
100% FREE customization

Country-wise Analysis

The Presence of Key Players in the Nucleotides Market is Souring Growth to the US Nucleotides Market

According to FMI, the US is dominating the North American region with a market share of 91.2% valued at US$ 175.6 Mn in the year 2021 and it is expected to reach US$ 286.7 Mn by the year 2031 growing at a CAGR of 5.6% over the forecasted period.

The presence of key players in the US is one of the major growth enablers to the US nucleotides market. These key players are focusing on changing consumer demand and hence introducing the products according to the need of the consumers. For instance, some manufacturers have introduced gluten-free nucleotide premix to the market. As the huge consumer base in the US are demanding gluten-free food products the demand for gluten-free ingredients such as nucleotides which are used in food products is also gaining traction. 

Growing Concern Regarding Infant Nutrition Promoting Sales of Nucleotides in Germany

The German nucleotides market size in 2021 is estimated to account for a value of US$ 33.6 Mn and it is expected to grow with a CAGR of 5.5% over the forecasted period reaching US$ 54.2 Mn

The key reason behind the dominance of Germany in the European nucleotides market is the growing demand for nucleotides in infant nutrition. From the past few years, the consumer base in Germany has become aware of the positive impact of nucleotides enriched baby food on infant nutrition. Thus the demand for nucleotides enriched baby food is souring growth to the German nucleotides market.

Increasing Incidences of Animal Diseases Promoting Sales of Nucleotides in the UK

Animals' nucleotides are digested in the gut, which has an impact on the proliferation of beneficial gut bacteria. ATP breakdown begins immediately after an animal dies due to respiratory arrest, resulting in the synthesis of catabolite nucleotides such as inosine (Ino), inosine monophosphate (IMP), and, later, hypoxanthine (Hx). Measuring nucleotide levels in tissues provides an objective indicator of the freshness of fish and meat, such as beef, pork, lamb, poultry, and sub-products.

Thus due to increasing incidents of animal diseases, the consumer base in the UK have become aware of maintaining adequate metabolism rates in livestock which is propelling growth to the UK nucleotides market.

Growing Demand for Food Products with High Nutritional Value is a Key Growth Enabler for the Nucleotides Market in India

India is dominating the South Asia nucleotides market holding a 40.6% share valued at US$ 2,242.2 Mn in the year 2021 and it is expected to grow with a CAGR of 9.7% reaching a market value of US$ 5,142.4 Mn by the year 2031.

Being one of the prominent developing countries the disposable income of the consumer base in India is continuously increasing. Thus with increasing disposable income consumers’ willingness to spend on nutritional food products is also increasing. Thus food product manufacturers are using ingredients such as nucleotides which help in increasing the nutritional value of the product. Hence the growing demand for nutritional food products is promoting sales of nucleotides in India.

Growing Demand for Flavour Enhancers is Triggering Growth to the Nucleotides Market in China

For the past few years, China is experiencing significant growth in the demand for flavour enhancers. As the nucleotides boost sensory acceptability through taste and flavour, increase the richness, impact, continuity, and harmony of food flavours. Moreover, it also enhances the performance of smells, and provide for cost savings in formulations. Owing to which the sales of nucleotides are expected to gain traction in China and it is expected to grow with a significant CAGR of 8.9% over the forecasted period.

Category-wise Insights

Diagnostic Research Dominating Application Segment of Nucleotides Market

According to FMI, the Diagnostic research segment is holding a market share of 62.0% valued at US$ 346.9 Mn in the year 2021 and it is expected to reach US$ 617.5 Mn by 2031 growing at a CAGR of 6.6%. From the past few years, the demand for quick and accurate diagnosis of numerous genetic diseases is increasing.

Thus with the growing demand for quick and accurate diagnosis, the demand for nucleotides is also increasing as it is one of the best alternatives available in the market for diagnostic research.

TaqMan Allelic Discrimination Technology is one of the Prominent Technology in the Nucleotides Market

According to FMI, TaqMan Allelic Discrimination technology is estimated to dominate the technology segment holding a 45.8% share in the global market valued at US$ 256.6 Mn in the year 2021 and it is expected to grow with 6.8% CAGR in the forecasted period.

TaqMan allelic discrimination, which has been widely used to define single nucleotide polymorphisms, is one of the most effective approaches to evaluate genotypes.

However, there are numerous disorders caused by massive deletions that can only be detected by copy number analysis, multiplex ligation-dependent probe amplification, or direct sequencing, all of which are time-consuming, expensive, and difficult to interpret and utilize in high-throughput research. Thus as an alternative approach, TaqMan allelic discrimination technology is used.

Nandini Roy Choudhury
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Competition Landscape: Top Nucleotides Companies

According to market research analysis Ohly GmbHNanjing Bio Together Co., Ltd., ThermoFisher Scientific Inc., Agilent Technologies Inc., DSM Nutritional Products Ltd., Lallemand Inc., Affymetrix Inc., PR omega Corporation, Biorigin, Meihua Group, Star Lake Bioscience Co., NuEra Nutrition, F. Hoffmann-La Roche Ltd., CJ CheilJedang Corporation and many other.

Companies today operate in a fast-paced business climate, guided by shifting consumer desires. To be relevant in the market, it is critical that they keep track of changing consumer tastes and preferences. Companies are focusing on the launch of products with unique qualities, driven by the increased demand for nutritional premixes.

Scope of Report

Attribute

Details

Market Size Value in 2020

US$ 529.2 Million

Market Forecast Value in 2031

US$ 1,010.5 Million

Global Growth Rate

6.1

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

MT for Volume and US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA

Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.

Key Market Segments Covered

Technology, Application and Regions

Key Companies Profiled

  • Ohly GmbH
  • Nanjing Bio Together Co., Ltd.
  • Agilent Technologies Inc.
  • PR omega Corporation
  • Biorigin
  • Meihua Group
  • Star Lake Bioscience Co.
  • NuEra Nutrition
  • Lallemand Inc.
  • Affymetrix Inc.
  • DSM Nutritional Products Ltd.
  • F. Hoffmann-La Roche Ltd.
  • ThermoFisher Scientific Inc.
  • CJ CheilJedang Corporation
  • Others

Pricing

Available upon Request

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Segments Covered in Nucleotides Industry Analysis

By Technology:

  • TaqMan allelic discrimination
  • SNP by pyrosequencing
  • Gene chips & microarrays
  • Others

By Application:

  • Food & beverage additive
  • Animal feed additive
  • Pharmaceuticals
  • Diagnostics research
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Frequently Asked Questions

Currently nucleotides market is worth more than US$ 529.2 Mn.

Nucleotides consumption is expected to grow at a CAGR of around 6.1% during the period 2021-2031.

In terms of revenue, nucleotides grew at a CAGR of around 4.9% during 2016-2020

Rising demand for better nutritive qualities in flavour enhancers is the latest trend of nucleotides being observed in the market.

Market players are opting for technological advancement, new product developments and production capacity expansion.

The top 5 producers of nucleotides hold around 20-30% of the market share.

The US, China Germany, and China are the major countries driving demand for nucleotides.

East Asia holds around 12.8% of the total nucleotides revenue share.

US nucleotides market is projected to grow at a CAGR of around 5.6% over the next ten years.

The report presents a detailed cost analysis of nucleotides based on nature i.e. organic and conventional.

A nucleotide is an organic molecule that is the building block of DNA and RNA.

Nucleotides are in particular essential for replication of DNA and transcription of RNA in rapidly dividing stages.

Table of Content

1. Market Overview

    1.1. Market Coverage / Taxonomy

    1.2. Market Definition / Scope / Limitations

2. The Massive Impact of the Crisis

    2.1. Global Nucleotide Market Forecast Scenario Comparison of Annual Growth Rates for short Term (2021-2025) and Long Term (2026-2031)

        2.1.1. Optimistic Scenario

        2.1.2. Likely Scenario

        2.1.3. Pessimistic Scenario

    2.2. Key Factors Impacting the Market

Note: Market Assessment shall be Provided for Likely Scenario

3. Market Dynamics

    3.1. Drivers

        3.1.1. Supply Side Drivers

        3.1.2. Demand Side drivers

        3.1.3. Economic Side Drivers

    3.2. Restraints

    3.3. Opportunity

    3.4. Market trends By Region

    3.5. Product Launches

    3.6. Product Claims & Nutritional Information Scan by Buyers

    3.7. Macro-Economic Factors

    3.8. Forecast Factors - Relevance & Impact

    3.9. Consumers Survey Analysis

4. Key Regulations

    4.1. Packaging & Labelling Regulations

    4.2. Certifications and Certifying Agency Overview

    4.3. Import/Export Policies

5. Value Chain Analysis

    5.1. Operating margins at each node of supply chain

    5.2. List of Active Market Participants

        5.2.1. Raw Material Suppliers

        5.2.2. Product Manufacturers

        5.2.3. Key Brands

6. Global Nucleotide Market Demand Analysis 2016-2020 and Forecast, 2021-2031

    6.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020

    6.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031

    6.3. Y-o-Y Growth Trend Analysis

7. Global Nucleotide Market - Pricing Analysis

    7.1. Regional Pricing Analysis (US$/Metric Tons) By Prominent Regions

    7.2. Pricing Break-up By category

    7.3. Global Average Pricing Analysis Benchmark

8. Global Nucleotide Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031, By Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Analysis By Technology, 2016 - 2020

    9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Technology, 2021-2031

        9.3.1. TaqMan allelic discrimination

        9.3.2. Gene chips & microarrays

        9.3.3. SNP by pyrosequencing

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Technology

10. Global Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2016 - 2020

    10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2021-2031

        10.3.1. Pharmaceuticals

        10.3.2. Diagnostics research

        10.3.3. Food & beverage additive

        10.3.4. Animal feed additive

        10.3.5. Others

    10.4. Market Attractiveness Analysis By Application

11. Global Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016 - 2020

    11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

        12.4.2. By Technology

        12.4.3. By Application

    12.5. Market Attractiveness Analysis

        12.5.1. By Technology

        12.5.2. By Application

    12.6. Market Trends

    12.7. Key Market Participants - Intensity Mapping

    12.8. Drivers and Restraints - Impact Analysis

13. Latin America Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        13.4.1. By Country

        13.4.2. Brazil

        13.4.3. Mexico

        13.4.4. Rest of Latin America

        13.4.5. By Technology

        13.4.6. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Technology

        13.5.2. By Application

    13.6. Market Attractiveness Analysis

    13.7. Market Trends

    13.8. Key Market Participants - Intensity Mapping

    13.9. Drivers and Restraints - Impact Analysis

14. Europe Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        14.4.1. By Country

        14.4.2. Germany

        14.4.3. Italy

        14.4.4. France

        14.4.5. U.K.

        14.4.6. Spain

        14.4.7. BENELUX

        14.4.8. Russia

        14.4.9. Rest of Europe

        14.4.10. By Technology

        14.4.11. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Technology

        14.5.2. By Application

    14.6. Market Attractiveness Analysis

    14.7. Market Trends

    14.8. Key Market Participants - Intensity Mapping

    14.9. Drivers and Restraints - Impact Analysis

15. East Asia Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        15.4.1. By Country

        15.4.2. China

        15.4.3. Japan

        15.4.4. South Korea

        15.4.5. By Technology

        15.4.6. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Technology

        15.5.2. By Application

    15.6. Market Attractiveness Analysis

    15.7. Market Trends

    15.8. Key Market Participants - Intensity Mapping

    15.9. Drivers and Restraints - Impact Analysis

16. South Asia Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        16.4.1. By Country

        16.4.2. India

        16.4.3. Thailand

        16.4.4. Indonesia

        16.4.5. Malaysia

        16.4.6. Singapore

        16.4.7. Rest of South Asia

        16.4.8. By Technology

        16.4.9. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Technology

        16.5.2. By Application

    16.6. Market Attractiveness Analysis

    16.7. Market Trends

    16.8. Key Market Participants - Intensity Mapping

    16.9. Drivers and Restraints - Impact Analysis

17. Oceania Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        17.4.1. By Country

        17.4.2. Australia

        17.4.3. New Zealand

        17.4.4. By Technology

        17.4.5. By Application

    17.5. Market Attractiveness Analysis

        17.5.1. By Technology

        17.5.2. By Application

    17.6. Market Attractiveness Analysis

    17.7. Market Trends

    17.8. Key Market Participants - Intensity Mapping

    17.9. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Nucleotide Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020

    18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031

        18.4.1. By Country

            18.4.1.1. GCC Countries

            18.4.1.2. North Africa

            18.4.1.3. South Africa

            18.4.1.4. Rest of Middle East and Africa

        18.4.2. By Technology

        18.4.3. By Application

    18.5. Market Attractiveness Analysis

        18.5.1. By Technology

        18.5.2. By Application

    18.6. Market Attractiveness Analysis

    18.7. Market Trends

    18.8. Key Market Participants - Intensity Mapping

    18.9. Drivers and Restraints - Impact Analysis

19. Key Countries Nucleotides Market Analysis 2016–2020 and Forecast 2021–2031

    19.1. U.S.

        19.1.1. Introduction

        19.1.2. Pricing Analysis (2016, 2021, 2031)

        19.1.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.1.3.1. By Technology

            19.1.3.2. By Application

    19.2. Canada

        19.2.1. Pricing Analysis (2016, 2021, 2031)

        19.2.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.2.2.1. By Technology

            19.2.2.2. By Application

    19.3. Brazil

        19.3.1. Pricing Analysis (2016, 2021, 2031)

        19.3.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.3.2.1. By Technology

            19.3.2.2. By Application

    19.4. Mexico

        19.4.1. Pricing Analysis (2016, 2021, 2031)

        19.4.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.4.2.1. By Technology

            19.4.2.2. By Application

    19.5. Argentina

        19.5.1. Pricing Analysis (2016, 2021, 2031)

        19.5.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.5.2.1. By Technology

            19.5.2.2. By Application

    19.6. Chile

        19.6.1. Pricing Analysis (2016, 2021, 2031)

        19.6.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.6.2.1. By Technology

            19.6.2.2. By Application

    19.7. Germany

        19.7.1. Pricing Analysis (2016, 2021, 2031)

        19.7.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.7.2.1. By Technology

            19.7.2.2. By Application

    19.8. Italy

        19.8.1. Pricing Analysis (2016, 2021, 2031)

        19.8.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.8.2.1. By Technology

            19.8.2.2. By Application

    19.9. France

        19.9.1. Pricing Analysis (2016, 2021, 2031)

        19.9.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.9.2.1. By Technology

            19.9.2.2. By Application

    19.10. U.K.

        19.10.1. Pricing Analysis (2016, 2021, 2031)

        19.10.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.10.2.1. By Technology

            19.10.2.2. By Application

    19.11. Spain

        19.11.1. Pricing Analysis (2016, 2021, 2031)

        19.11.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.11.2.1. By Technology

            19.11.2.2. By Application

    19.12. Benelux

        19.12.1. Pricing Analysis (2016, 2021, 2031)

        19.12.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.12.2.1. By Technology

            19.12.2.2. By Application

    19.13. Russia

        19.13.1. Pricing Analysis (2016, 2021, 2031)

        19.13.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.13.2.1. By Technology

            19.13.2.2. By Application

    19.14. India

        19.14.1. Pricing Analysis (2016, 2021, 2031)

        19.14.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.14.2.1. By Technology

            19.14.2.2. By Application

    19.15. Thailand

        19.15.1. Pricing Analysis (2016, 2021, 2031)

        19.15.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.15.2.1. By Technology

            19.15.2.2. By Application

    19.16. Indonesia

        19.16.1. Pricing Analysis (2016, 2021, 2031)

        19.16.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.16.2.1. By Technology

            19.16.2.2. By Application

    19.17. Malaysia

        19.17.1. Pricing Analysis (2016, 2021, 2031)

        19.17.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.17.2.1. By Technology

            19.17.2.2. By Application

    19.18. China

        19.18.1. Pricing Analysis (2016, 2021, 2031)

        19.18.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.18.2.1. By Technology

            19.18.2.2. By Application

    19.19. Japan

        19.19.1. Pricing Analysis (2016, 2021, 2031)

        19.19.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.19.2.1. By Technology

            19.19.2.2. By Application

    19.20. South Korea

        19.20.1. Pricing Analysis (2016, 2021, 2031)

        19.20.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.20.2.1. By Technology

            19.20.2.2. By Application

    19.21. Australia

        19.21.1. Pricing Analysis (2016, 2021, 2031)

        19.21.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.21.2.1. By Technology

            19.21.2.2. By Application

    19.22. New Zealand

        19.22.1. Pricing Analysis (2016, 2021, 2031)

        19.22.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.22.2.1. By Technology

            19.22.2.2. By Application

    19.23. GCC Countries

        19.23.1. Pricing Analysis (2016, 2021, 2031)

        19.23.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.23.2.1. By Technology

            19.23.2.2. By Application

    19.24. Central Africa

        19.24.1. Pricing Analysis (2016, 2021, 2031)

        19.24.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.24.2.1. By Technology

            19.24.2.2. By Application

    19.25. Northern Africa

        19.25.1. Pricing Analysis (2016, 2021, 2031)

        19.25.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.25.2.1. By Technology

            19.25.2.2. By Application

    19.26. South Africa

        19.26.1. Pricing Analysis (2016, 2021, 2031)

        19.26.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031

            19.26.2.1. By Technology

            19.26.2.2. By Application

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Company Share Analysis of Top Players

    20.3. Market Presence Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Deep Dive (Tentative List)

        21.2.1. Ohly GmbH

            21.2.1.1. Overview

            21.2.1.2. Product Portfolio

            21.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.1.4. Sales Footprint

            21.2.1.5. Strategy Overview

                21.2.1.5.1. Marketing Strategy

                21.2.1.5.2. Product Strategy

        21.2.2. Nanjing Bio Together Co., Ltd.

            21.2.2.1. Overview

            21.2.2.2. Product Portfolio

            21.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.2.4. Sales Footprint

            21.2.2.5. Strategy Overview

                21.2.2.5.1. Marketing Strategy

                21.2.2.5.2. Product Strategy

        21.2.3. Agilent Technologies Inc.

            21.2.3.1. Overview

            21.2.3.2. Product Portfolio

            21.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.3.4. Sales Footprint

            21.2.3.5. Strategy Overview

                21.2.3.5.1. Marketing Strategy

                21.2.3.5.2. Product Strategy

        21.2.4. PR omega Corporation

            21.2.4.1. Overview

            21.2.4.2. Product Portfolio

            21.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.4.4. Sales Footprint

            21.2.4.5. Strategy Overview

                21.2.4.5.1. Marketing Strategy

                21.2.4.5.2. Product Strategy

        21.2.5. Biorigin

            21.2.5.1. Overview

            21.2.5.2. Product Portfolio

            21.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.5.4. Sales Footprint

            21.2.5.5. Strategy Overview

                21.2.5.5.1. Marketing Strategy

                21.2.5.5.2. Product Strategy

        21.2.6. Meihua Group

            21.2.6.1. Overview

            21.2.6.2. Product Portfolio

            21.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.6.4. Sales Footprint

            21.2.6.5. Strategy Overview

                21.2.6.5.1. Marketing Strategy

                21.2.6.5.2. Product Strategy

        21.2.7. Star Lake Bioscience Co.

            21.2.7.1. Overview

            21.2.7.2. Product Portfolio

            21.2.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.7.4. Sales Footprint

            21.2.7.5. Strategy Overview

                21.2.7.5.1. Marketing Strategy

                21.2.7.5.2. Product Strategy

        21.2.8. NuEra Nutrition

            21.2.8.1. Overview

            21.2.8.2. Product Portfolio

            21.2.8.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.8.4. Sales Footprint

            21.2.8.5. Strategy Overview

                21.2.8.5.1. Marketing Strategy

                21.2.8.5.2. Product Strategy

        21.2.9. Lallemand Inc.

            21.2.9.1. Overview

            21.2.9.2. Product Portfolio

            21.2.9.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.9.4. Sales Footprint

            21.2.9.5. Strategy Overview

                21.2.9.5.1. Marketing Strategy

                21.2.9.5.2. Product Strategy

        21.2.10. Affymetrix Inc.

            21.2.10.1. Overview

            21.2.10.2. Product Portfolio

            21.2.10.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.10.4. Sales Footprint

            21.2.10.5. Strategy Overview

                21.2.10.5.1. Marketing Strategy

                21.2.10.5.2. Product Strategy

        21.2.11. DSM Nutritional Products Ltd.

            21.2.11.1. Overview

            21.2.11.2. Product Portfolio

            21.2.11.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.11.4. Sales Footprint

            21.2.11.5. Strategy Overview

                21.2.11.5.1. Marketing Strategy

                21.2.11.5.2. Product Strategy

        21.2.12. F. Hoffmann-La Roche Ltd.

            21.2.12.1. Overview

            21.2.12.2. Product Portfolio

            21.2.12.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.12.4. Sales Footprint

            21.2.12.5. Strategy Overview

                21.2.12.5.1. Marketing Strategy

                21.2.12.5.2. Product Strategy

        21.2.13. ThermoFisher Scientific Inc.

            21.2.13.1. Overview

            21.2.13.2. Product Portfolio

            21.2.13.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.13.4. Sales Footprint

            21.2.13.5. Strategy Overview

                21.2.13.5.1. Marketing Strategy

                21.2.13.5.2. Product Strategy

        21.2.14. CJ CheilJedang Corporation

            21.2.14.1. Overview

            21.2.14.2. Product Portfolio

            21.2.14.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.14.4. Sales Footprint

            21.2.14.5. Strategy Overview

                21.2.14.5.1. Marketing Strategy

                21.2.14.5.2. Product Strategy

        21.2.15. Others Prominent Players

            21.2.15.1. Overview

            21.2.15.2. Product Portfolio

            21.2.15.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.15.4. Sales Footprint

            21.2.15.5. Strategy Overview

                21.2.15.5.1. Marketing Strategy

                21.2.15.5.2. Product Strategy

22. Assumptions and Acronyms Used

23. Research Methodolog

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Nucleotides Market Value (US$ Mn) and Forecast by Region, 2016–2020

Table 2: Global Nucleotides Market Value (US$ Mn) and Forecast by Region, 2021–2031

Table 3: Global Nucleotides Market Volume (Metric Tons) and Forecast by Region, 2016–2020

Table 4: Global Nucleotides Market Volume (Metric Tons) and Forecast by Region, 2021–2031

Table 5: Global Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 6: Global Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 7: Global Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 8: Global Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 9: Global Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 10: Global Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 11: Global Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 12: Global Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 13: North America Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 14: North America Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 15: North America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 16: North America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 17: North America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 18: North America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 19: North America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 20: North America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 21: North America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 22: North America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 23: North America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 24: North America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 25: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 26: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 27: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 28: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 29: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 30: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 31: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 32: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 33: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 34: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 35: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 36: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 37: Europe Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 38: Europe Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 39: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 40: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 41: Europe Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 42: Europe Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 43: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 44: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 45: Europe Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 46: Europe Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 47: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 48: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 49: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 50: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 51: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 52: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 53: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 54: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 55: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 56: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 57: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 58: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 59: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 60: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 61: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 62: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 63: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 64: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 65: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 66: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 67: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 68: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 69: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 70: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 71: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 72: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 73: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 74: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 75: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 76: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 77: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 78: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 79: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 80: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 81: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 82: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 83: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 84: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Table 85: MEA Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020

Table 86: MEA Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031

Table 87: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020

Table 88: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031

Table 89: MEA Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020

Table 90: MEA Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031

Table 91: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020

Table 92: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031

Table 93: MEA Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020

Table 94: MEA Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031

Table 95: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020

Table 96: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031

Nandini Roy Choudhury
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Nucleotides Market Value (US$ Mn) and Volume (MT) Forecast, 2021–2031

Figure 02: Global Nucleotides Market Absolute $ Opportunity (US$ Mn), 2021?2031

Figure 03: Global Nucleotides Market Value (US$ Mn) and % Growth by Region, 2021 & 2031

Figure 04: Global Nucleotides Market Y-o-Y Growth Rate by Region, 2021 - 2031

Figure 05: Global Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 06: Global Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 07: Global Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 8: Global Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 9: Global Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 10: Global Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 11: North America Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031

Figure 12: North America Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 13: North America Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 14: North America Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 15: North America Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 16: North America Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 17: North America Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 18: North America Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 19: North America Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 20: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031

Figure 21: Latin America Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 22: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 23: Latin America Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 24: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 25: Latin America Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 26: Latin America Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 27: Latin America Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 28: Latin America Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 29: Europe Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031

Figure 30: Europe Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 31: Europe Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 32: Europe Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 33: Europe Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 34: Europe Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 35: Europe Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 36: Europe Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 37: Europe Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 38: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031

Figure 39: East Asia Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 40: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 41: East Asia Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 42: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 43: East Asia Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 44: East Asia Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 45: East Asia Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 46: East Asia Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 47: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031

Figure 48: South Asia Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 49: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 50: South Asia Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 51: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 52: South Asia Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 53: South Asia Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 54: South Asia Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 55: South Asia Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 56: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031

Figure 57: Oceania Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 58: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 59: Oceania Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 60: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 61: Oceania Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 62: Oceania Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 63: Oceania Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 64: Oceania Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031

Figure 65: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031

Figure 66: Middle East & Africa Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031

Figure 67: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031

Figure 68: Middle East & Africa Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031

Figure 69: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031

Figure 70: Middle East & Africa Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031

Figure 71: Middle East & Africa Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031

Figure 72: Middle East & Africa Nucleotides Market Attractiveness Analysis by Application, 2021 – 2031

Need specific information?

Request Customization

Explore Food and Beverage Insights

View Reports

Recommendations

Food and Beverage

Customized Premixes Market

Published : October 2020

Food and Beverage

Food Flavour Enhancer Market

Published : January 2022

Food and Beverage

Infant Formula Market

Published : August 2021

Food and Beverage

Feed Premix Market

Published : June 2020

Google translate